Upgrade to SI Premium - Free Trial

Cellebrite (CLBT) PT Lowered to $15 at TD Cowen

August 13, 2026 3:58 PM
TD Cowen analyst Shaul Eyal lowered the price target on Cellebrite (NASDAQ: CLBT) to $15.00 (from $23.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change